MOORE MUSGROVE LEUKAEMIC GROUP SOMERSET Raising funds for the benefit of Patients in sonr$¢t UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 29 FEBRUARY 2024 REGISTERED CHARITY NUMBER 1036580
MUSGROVE LEUKAEMIC GROUP SOMERSET Raising funds for the benefit of Pgtients in Somerset TRUSTEES ANNUAL REPORT FOR THE YEAR ENDED 29 FEBRUARY 2024 REFERENCE AND ADMIIYISTRATION DETAILS CharAty name: Registered Charity number: Charity's principal address: Musgrove Leukaemic Group Som¢rset 1036580 16 Durleigh Road BRIDGWATER Somerset TA6 7HR Trustees: Mrs Patricia Reed (Chairperson) Miss Jane Allin (Secretary) Mrs Maureen Hudson Mrs Margaret Smith Mr Bernard Reed (Treasurer) Mrs Pat Cornish Mr David Edwards Mrs Margaret Edwards (resigned 12.7.23) Mrs Christine Regan (resigned 12.7.23) Professional Advisors Bankers: National We5tmin5ter Bank plc 26127 Fore Street TAUNTON Somerset Independent Examiner: Moor¢ Chartered Accountants 6th Floor Whitefriars Lewins Mead Bristol BSI 2Nr STRUCTURE GOVERNANCE AND MANAGEMENT Musgrove Leukaemic Group Somerset is a registered charity and has been constituted as an unincorporated association governed by a fornial constitution. A copy of the constitution may b¢ obtain¢d on application to the Secretary. Trustees are elected at each Annual General Meeting but retiring Trustees are eligible for re- election. Thc oificers may hold office until retirement or by removal at an Annual Gen¢ral Meeting. Co-opted Trustees may be appointed by the Committee at any time and generally have special knowledge or experience with leukaemia or related conditions. They nY serve for such period as decided by the Committee or by their retirement.
MUSGROVE LEUKAEMIC GROUP SOMERSET Ralslng funds for the benefit of Padents in Somerset TRUSTEES ANNUAL REPORT FOR THE YEAR ENDED 29 FEBRUARY 2024 (contlnued) OWECTIVES AND ACTIVITIES The Charityls Objeclives and activitiesfor the Publlc Benefit The objects of the Group are to relieve persons suffering from L¢ukaemia and associated conditions by assisting and funding th¢ tr¢atm¢nts and welfare of such persons at Musgrove Park Hospitsl, Taunton Somerset or any other area authorised by the medical staff. The Group carries out these objects by: Sponsoring the mcdical staff that are LX)nsidered key by the Somerset NHS Foundation Trust to maintaining Musgrove Park Hospital as a centre for the treatment of Leukaemia and other related discascs. The grants made to nursing staff for training are in an aspect which wh¢n complcted will enhance the experience of Leukaemia patients whilst receiving treatment for Leukaemia and other related discases. The purchase of equipment and furniture is made following recomm¢ndations from the medical staff with a view to improving the quality of th¢ treatsnent and the emotional and physical well- being of both suffers and relatives. Chqrity Or8anisa¢lon and History The Musgrove Leukaemic Group Somerset was launched in 1978 and is nm completely by unpaid volunteers who absorb all their own personal expense5. There are no paid Officers and overheads are kept to an absolute minimurn thereby ensuring that most of the funds raised goes to the Haematology Unit at Musgrove Park Hospital, Taunton. The hospital has beeA)me a major ¢¢ntr¢ in the South West for the diagnosis and trtsMent of Icukaemia and r¢lat¢d blood disorders. In general the aims of the Group are as follows: To maintain Musgrovc Park Hospital as a major centre for the diagnosis and treatment of leukaemia and related blood disorders by th¢ most up-to-date techniques. ii) To keep the public inforn)ed on progress b¢ing made on the diwosis and treatment of these diseases. The Group meets regularly in Bridgwat¢r and Taunton.
MUSGROVE LEUKAEMIC GROUP SOMERSET Raising funds for the beneflt of Patlents In Somerset TRUSTEES ANNUAL REPORT FOR THE YEAR ENDED 29 FEBRUARY 2024 (continued) Policy is discussed at both Group and Committcc meetings, but the Committee has the duty to manage the Group and the power to ultimately make executive decisions. The Group has area representatives cov¢ring Som¢rsct at Bridgwater, Burnham on Sea, Clwd and Ilminster, Min¢head. Taunton, and Wellington. The area representatives act as local contacts organising events and visiting various businesses, people or other organisations as requir¢d. In turn they report back to Group meetings on a regular basis. ACHIEVEMENTS AND PERFORMANCE Chairperson's Report It is pleasing to report that the Group has been able to recommence fvnding projects at Mus8rove Park Hospital now that the restrictions imposed by the pandemic have been removed. In the last financial year, we have purchased 6 new chemotherapy chairs for the Beacon Centre Day Unit and those previously purchased have been moved to the new unit at Wellington Hospitsl. A Vital Signs monitor has been purchased which helps the medical team assess patient's fitness to undergo treath)ent. A variety of equipment has been purchased for the Mdusa room which is used by the Consultants to revi¢w paticnts, treatment, Sound proofin8 has been made to the Consulting Roorns in the Beacon Centre to ensure patient privacy. A new Ambulatory Room has been established on Ward 9 and the Group have funded the equipment and furniture required. The NHS Trust had one pool car. To ensure the haernatology nurses had transport for the clinics at Bridgwater and Wellington th¢ MLGS is sponsoring a pool car for that specific purpose. It is hoped in the future to provide a clinic at Williton. The Gmup has received requests to fund additional equipment for the Ambulatory Room. The bathroom on Ward 9 is now unfit for purpose so funding is requir to create a new wet room. It is hopeAI to restore the complementary therapy service on Ward 9 once a week. Funds are held to support these projects and any other project that falls within our constitution to enable the Taunton and Somerset Foundation Trust to meet the needs of the patients. I would like to thank the officers and committee members for their CntinUed commitment through this difficult period. Trlda Reed Chairperson
MUSGROVE LEUKAEMIC GROUP SOMERSET Raising funds for the beneflt of Patfients In Somerset TRUSTEES ANNUAL REPORT FOR THE YEAR ENDED 29 FEBRUARY 2024 (continued) Consul¢ant s Report It has bccn a long time since our last report has been produced and inevitability there has been a number of updates and changes in the intervening 5 years. Not least thc dcpartment, trust and the NHS has bccn through a pandemic which has significantly affected the health service and the charity group sector. In addition, the trust has undergon¢ a m¢rgcr with Yeovil hospital. In the haematology dcpartment there have been a number of changes in personnel, in fact almost as many as the number of prime ministers we hav¢ had. Ha¢matology nSultantS Simon Davis, Sarah Alford and our previous MLGS President Simon Bolam have all retired from clinical duties with myself taking over the President role of the MLGS. I am pleased to report that we have been able to successfully replace and recruit into these posts and we welcome our new consultant coll¢agucs: Olivw Miles was prcviously working at Gloucester. Martin Best and Loredana Mihailescu were both trainees with us. so it is particularly nice to see them r¢turning as consultants. We also welcome our newly fvnded roles of Hospital Speciality Trust doctors, Pratima lyer and Desmond Maitland. We have also managed to increase the number of CNSS to scvcn to assist with our increasing patient workload. With th¢ trust merger the CNS roles at the two acute tsusts have been consolidated to one body with all CNSS covering both sites. Emma Storey has managed a whole maternity leave in between these updates- many ConatUlatIOnS on the birth of her son, We have also had a number of changes in our administration teams and not least the retirement of Shirley Bennett. Despite these changes over the years, we have ntInued to strive to improve the department and outcomes for patients. As well the personnel the way of working in the department has also radically changed not l¢&st to Cat for the inevitable increase in pati¢nts ne¢ding our carc but also rather gloriously the new wave of drugs available which are revolutionizing the way we treat our patients. In this regard we do have to acknowl¢dg¢ th¢ charity sector such as ours which help provide care to patients but also help develop these new drugs based on basic scientific and genomic research. Therefore, l am pleased to report that despite the turbul¢nt ¢conomic background the MLGS continues to strive thanks of the generosity of the public and of former patients who keep providing donations. We are in thc happy position to report that we have a surplus which we have been able to use to good effect. We are funding a car loan deal which is used by our outr¢ach nurses to providc chemotherapy and supportive m¢dications in the community throughout Somerset and has been eatly welcomed by patients. This has effectively replaced th¢ old 'Bumble' bus s¢rvice- sadly a victim of the pandemic. We have also been managed to furnish our haematology day unit he at Musgrove Park with n¢w stat¢ of thc art specifically designed Chairs. We have funded the development and furnishing of the ambulatory care service project adjacent to Ward 9. This results in patients who are receiving intensiv¢ Chall0thapy to go home daily rather than a block of 5 weeks stuck in a ward room. In additio funds have been released to fit ward 9 with further equipm¢nt including a new bladder scanner, cardiac monitoring hardware, a television for the ambulatory Care room, hand grip patient assessment tool as w¢ll as fillthcr funds canned for bathroom conversions and more CAD pumps to deliver ambulatory chemotherapy. We also used
MUSGROVE LEUKAEMIC GROUP SOMERSET Ralslng funds for the benefit of Patlents In Somerset TRUSTEES ANNUAL REpoirr FOR THE YEAR ENDED 29 FEBRUARY 2024 (continued) funding to purchase a dictation syst¢m to enablc L*)eSpOndence to be sent promptly to patients after clinic appoinknents, as we had a significant backlog of correspondence not ablc to be typed up and thus not getting to our GP coll¢agues and patients. We have also funded renovations to enable to make the clinic rooms soundproof. Once agai the haematology dartrncnt are overjoyed to have the SUpt of the MLGS and we hope that we can use these funds wisely to improve the care and offer wc can provide to the p¢ople of Somerset. Deepak MaDnarl Consultant Haematolo FINANCIAL REVIEW Treasurers Report Ih The total raised for the year ended 29 February 2024 amount¢d to £47,814. th The total expenditure for the year ended 29 February 2024 is £25,938. Ih The totsl raised since forniation as at the 29 of February 2024 is £4,077, l 97. The year ending February 2024 has seen a continued restricted fimdraising activity. Unfortunately, this could bcLx)me the nonn going forward, therefore the continued support of our regular contributors, donors, and friends plus the dedicateAI work of th¢ Trustees and Members is essential to enable the Group to continue to support projects at Mus8rove Park Hospital. The Trustees, members and volunteers absorb all their own ¢xpcnscs, so overheads are minimal and arc currently under l 0/0 of fimds raised. Thc mus0Ve Leukaemic Group Somerset is in a sound financial position because of the large legacies received in the financial y¢ar cnding 2022 that resulted in the Group's income for that year being £535,405. The Covid Pandernic prevented projects proceeding at the NHS TTht which has sultd in the retained funds held. It is not the Trustees intention to hold these monies in reserves. D¢tail¢d accounts are atthed for inspection.
MUSGROVE LEUKAEMIC GROUP SOMERSET Raising funds for the benefit of Patlents In Somerset TRUSTEES ANNUAL REPORT FOR THE YEAR ENDED 29 FEBRUARY 2024 (continued) Reserves Pollcy Musgrovc Lcukaemic Group Somerset (MLGS) retains reserves, and this document explains our policy. In dcfining this policy the Trustees have considerd; l ) tnLX)me forecasts for future years taking into account the reliability of each source of income and the potential for securing new incom¢ from alternativ¢ sOU¢s. 2) Exp¢nditur¢ forecasts for future years. 3) The need to hold reserves should a medical breakthrough necessitate the urgent purchase of new equipment. 4) The need to hold reserves to meet our immediate LX)mmitsnents should income levels drastically fall. The Group attempts to maintain reserves of approximately £200,0, which is represented by c&sh on short-tenn deposit and in the Group bank accounts. The present level of retained funds results from several legacies received in the financial year ending 2022, it is not the Trustees intention to hold these funds as reserves. The Group believes it is prudent to keep this level of surplus to.. l ) Ensure the Group can maintain its commitsnent to fund research salaries and consumables for year periods and to be able to so even if incom¢ l¢v¢ls should substantially fall for a period sufficient to allow alternative arrangements to be made. 2) To provide equipment on urscnt request if the ned should lSe. 3) To act as a buffer against any unforeseen eventuality. Our levels of reserves are constantly monitored and reviewed both at Group meetings and Committee meetings. The present level of Reserves is considered appropriate to enable the Group to meet our commitments for the financial year ending 2025. Th¢ receipts reccivcd in 2022 h&8 resulted in the Musgrove Leukaemic Group Somerset being in a strong financial position. Bernard Reed HOD. Treasurer.
MUSGROVE LEUK4EMIC GROUP SOMERSET Raislng funds for the beneflt of Patients ID Somerset TRUSTEES ANNUAL REPORT FOR THE YEAR ENDED 29 FEBRUARY 2024 (continued) Trustees, annual report Th¢ Mus8rovc Lcukaemic Group Somerset (MLGS) was fonned in April 1978 by a group of parents whose children were undergoing treatment for Icukaemia. Due to the limited facilities at Musgrovc Park Hospital they had to visit hospitals in Southampton and Bristol for trealment, placing severe strain on the families. Th¢ PreAt Trustecs are a group of people continuing to fundraise to improve the facilities for leukaemia and lymphoma patients and their families in Somers¢t. The funds raised by the MLGS are utiliscd to purchases equipment for the wards to improve the experience of patients whilst undergoing treatment. The MLGS has now raised over £4 Million, 959/0 of which has/is being made available to Muswve Park H05Pitals' Hacmatology/Oncology and Children's Unit because all the TnteeS and members services are voluntary. The Trustees have approved several new projects to be completed in 2024 that will reduce the retained funds held. Th¢ funds are raisa by various means but principally from donations includin8 le8aci¢s, collections, and other fundraisin8 ¢v¢nts. Our aim is to continue to raise fimds to improve the hospitsl experience for leukaemia and lymphoma patients.
MUSGROVE LEUKAEMIC GROUP SOMERSET Raislng funds for the benefit of Patlents In Somerset TRUSTEES ANNUAL REPORT FOR THE YEAR ENDED 29 FEBRUARY 2024 (continued) STATEMENT OF TRUSTEES RESPONSIBILrriES Charity law requires the trustees to prepare financial statements for each financial year which show a true and fair view of the state of affairs of th¢ charity and its financial activities for that period. In prcparing those financial statements, the trustees are requireAI to Select suitable aceA)unting policies and then apply them consistently; Makc judgements and tiMat¢S that are reasonable and prudent. Statc whether applicable accounting standards and statements of recomrn¢nded practice have been followcd, subject to any dartU disclosed and explained in the financial statements. and Prepare the financial statements on the going concern basis unlcss it is inappropriate to prcsume that the charity will continue in operational existence. The Trustees are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the charity and to enable them to ensure that the financial statements comply with the Charities Act 2011. They are also responsibl¢ for safeguarding the assets of th¢ charity and hence for taking reasonable steps for the prevention and d¢t¢ction of fraud and other irregularities. DECLARATION The Trustees declare that they have approved the Trustees, Report. Signed on behalf of the charity's trustees: 12 tk fu AJ r 2tJl Trlcla Reed Chair
MUSGROVE LEUKAEMIC GROUP SOMERSET Raising funds for the benefit of Patients in Somerset Independent Examiner's Report to the Trustees of Musgrove Leukaemic Group Somerset I report on the accounts of Musgrove Leukaemic Group Somerset for the year ended 29 February 2024 which are set out on pages 10 to 13. Respeelive responsibilities of trustees and examiner The charity's trustees are responsible for th¢ preparation of the accounts. The charity's trustees consider that an audit is not required for this year under section 144 of the Charitics Act 2011 (the Charities Act) and that an independent examination is nceded. It is my responsibility to: examine the accounts under section 145 of the Charities Act. to follow the procedures laid down in the general Directions given by the Charity Commissioners (under section 145 (5) (b) of the Charitie5 Act). and to state whether particular matters have come to my attention. Bagls of independent examiner's report My examination was carried out in accordance with the general Directions given by the Charity Commission, An examination includes a review of the accounting records kept by the charity and a comparison of the accounts presented with those records. It also includes consideration of any unusual items or disclosures in the accounts and seeking explanations from you as trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit, and consequently no opinion is given as to whether the accounts present a 'true and fair, view and the report is limited to those matters set out in the statement below. Independent examiner's 8tatemeDt In connection with my examination, no matter has come to my attention: i) which gives me reasonable cause to believe that An. any material respecL the requirements to keep accounting records in accordance with section 130 of the Charities Act; and to prepare accounts which accord with the accountAng records and comply with the accounting requirements of the Charities Act have not been me: or 2) to which, in my opinion, attention should be drawn in order to enable a prOr underst ding of the accounts to be reached. Mark Powell Moore 6 Floor l¥hitefriars Lewins Mead Bristol BSI 2NT Date:
MUSGROVE LEUKAEMIC GROUP SOMERSET Raislng funds for the beneflt of Patlents In Somerset STATEMENT OF FINANCIALACTIVITIES FOR THE YEAR ENDED 29 FEBRUARY 2024 Unrestrlcted Restrlcted Total Funds Total Fundj Funds Funds 2024 2023 INCOME & EXPENDITURE Incomlng Resources Donations, legacies and similar incoming resources.. Donations 10,671 Fund Raising 8,242 Collections 1,558 Covenants & Gift Aid (including tax recovered) 10,671 8,242 1,558 35,665 6.398 1.388 2,405 2,405 3.299 Investment Inwme: Bank Interest 24,938 24,938 7,280 TOTAL IIYCOMING RESOURCES 47,814 47,814 54,030 Resources Expended Note Direct Charitabl¢ Expenditure 2 Fund Raising and Publicity Management and Administration 24.743 209 24,743 209 1,145 986 986 962 TOTAL RESOURCES EXPENDED 25,938 25,938 2,107 NET (OUTYINFLOW OF RESOURCES FOR THE YEAR AND MOVEMENT IN FUF4DS 21,876 21,876 51,923 Balance brought forward at l March 2023 889,393 889093 837,470 BALANCES CARRIED FORWARD AT 29 FEBRUARY 2024 911,269 911269 889,393 io
MUSGROVE LEUKAEMIC GROUP SOMERSET Raising funds for the beneflt of Patients In Somerset BALANCE SHEET AS AT 29 FEBRUARY 2024 2024 2023 Note CURRENT ASSETS Debtors Short tenn deposits Cash at bank and in hand 722 750,000 160,967 587 505,943 384,737 911,689 891,267 CREDITORS: Amounts falling due within one year 420 1,874 TOTAL NET ASSETS 911369 889,393 Funded by: UNRESTRICTED FUNDS General Fund 911369 889,393 These accounts approved by the TnteeS on. I x Zo 2 4 Bernard Reed Treasurer For and on behalf of the Trustees Jane Allin Secretary 11
MUSGROVE LEUKAEMIC GROUP SOMERSET Ral$lng funds for the benetit of Patients in Somerset NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 29 FEBRUARY 2024 ACCOUNTIIYG POLICIES Aceounthig basls and standards The financial statements have been prepared under the historical cost Lnvention and in accordance with applicable accounting standards. th¢ Clwities SORP (FRS102) (Acwunting and Reporting by Charities) and comply with the Chariti¢s (Accounts and Reports) Regulations 2008 ISSU under the Charities Act 2011. b) Voluntary Income Voluntary income is received from a number of sources, including donations, collections and other fvnd raising Cvcnts. Such income is included in 11 in the income and expenditure account when received. Restricted And Unrestricted Funds Where appropriate, the accounts distinguish between restricted and unrestricted funds. The forn]er are received from donors and are subject to restrictions on the purpose for which they may be used. Unrestricted fvnds are those where there are no externally imposed r¢strictions which the charity may use at its discretion to achieve its objectives. In the opinion of the Officers the Charity does not operate any restricted funds. d) Short Term Deposlts Short tem] deposits represent monies placed on d¢posit with National Westminster Bank Treasury Rcscrve Centre. Bank Interest Bank Interest is crlted to the income and expenditure acUnt when received. Covenants Covenants are credited to the incom¢ and expenditure account when received. Provision is made for recoverable income tax arising from the LX)venants. 12
MUSGROVE LEUKAEMIC GROUP SOMERSET Ralslng funds for the benefit of PAtlents in Somerset NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 29 FEBRUARY 2024 (Continued) Taxatlon Musgrove Leukaemic Group Somerset is a regist¢red charity and the results of its nonnal activities are not liable to corporation tax. Unregtrl¢ted Restricted Total Funds Total Funds Funds Funds 2024 2023 DIRECT CHARITABLE EXPENDITURE (Amounts payable in furtherance of the Charities objects): Clinical unit grants Complimentary medicine grants Chemotherapy pool car ant 19,259 19,259 1.454 (309) 5,484 5,484 24.743 24,743 1,145 The above grants were made in support of Musgrove Park Hospital in Taunton. FUND RAISING AND PUBLICITY Fund raising costs Publications 209 209 209 209 13
MUSGROVE LEUKAEMIC GROUP SOMERSET Ralslng funds for the benefit of Patlents In Somerset NOTES TO THE ACCOUNTS FOR THE YEAR ENDED 29 FEBRUARY 2024 (Continued) Unrestrleted Restricted Total Funds Total Funds Funds Funds 2024 2023 MANAGEMENT AND ADMINISTRATION OF CHARITY Public liability insurance Ind¢p¢nd¢nt examiners fees 566 420 566 420 542 420 986 986 962 DEBTORS Income tax recoverable 722 587 CREDITORS: Amounts falllng due wlthlD one year Accountancy accnwl Clinical unit antS accrual 420 420 1,454 420 1,874 Balance Net movement Balance 1.3.23 funds 29.224 uNREsTRIED FUNDS General Fund 889.393 21,876 911,269 14